Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|May 9, 2008
Utility of the ovariectomized rat as a model for human osteoporosis in drug discoveryYogendra P Kharode, Michael C Sharp, Peter V N BodineJournal of Cellular Physiology|October 18, 2006
Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1Peter V N Bodine, Laura Seestaller-Wehr, Yogendra P Kharode, et al.Molecular Endocrinology (Baltimore, Md.)|March 22, 2008
Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in miceAmelia L M Sutton, Xiaoxue Zhang, Diane R Dowd, et al.Endocrinology|June 18, 2005
Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivityBarry S Komm, Yogendra P Kharode, Peter V N Bodine, et al.Bone|December 14, 2004
In vitro and in vivo activities of C-terminally truncated PTH peptides reveal a disconnect between cAMP signaling and functional activityRichard J Murrills, Jeanne J Matteo, Rachelle L Samuel, et al.Journal of Cellular Biochemistry|September 5, 2002
Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic miceGadi Turgeman, Yoram Zilberman, Shuanhu Zhou, et al.Molecular Endocrinology (Baltimore, Md.)|February 21, 2004
The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult micePeter V N Bodine, Weiguang Zhao, Yogendra P Kharode, et al.Endocrinology|September 23, 2003
Evaluation of an estrogen receptor-beta agonist in animal models of human diseaseHeather A Harris, Leo M Albert, Yelena Leathurby, et al.The Journal of Pharmacology and Experimental Therapeutics|December 16, 2011
Osteogenic effects of a potent Src-over-Abl-selective kinase inhibitor in the mouseRichard J Murrills, Shoichi Fukayama, Frank Boschelli, et al.Journal of Medicinal Chemistry|October 28, 2009
(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: a wingless beta-catenin agonist that increases bone formation rateJeffrey C Pelletier, Joseph T Lundquist, Adam M Gilbert, et al.Pageof 1